Mesenteric panniculitis: therapeutic aspects in the light of a clinical case
pdf

Keywords

mesenteric panniculitis
mesenteric sclerosis
corticosteroids

How to Cite

GOREA, A., STOICA, M., SCORPAN, A., SARBU, O. and ISTRATI, V. (2022) “Mesenteric panniculitis: therapeutic aspects in the light of a clinical case”, One Health & Risk Management , 3(2), pp. 32-36. Available at: https://journal.ohrm.bba.md/index.php/journal-ohrm-bba-md/article/view/312 (Accessed: 28June2025).

Abstract

Introduction: Mesenteric panniculitis is a rare medical condition. Its incidence is between 0.16% - 3.4%. The small number of cases of PMN and the ignorance of its causes, pathogenesis and treatment significantly affect the prognosis of the disease.

Materials and methods: An analysis of the literature and the case of patient R, aged 47, who is admitted to IMSP, is presented.

Results: Accusations: peri-umbilical pain, marked physical asthenia and significant weight loss. In the left abdominal flank, a tumor of 9.0 x14.0 cm was palpated, soft as consistensy, elastic, sensitive to palpation, fixed to the deep planes. Clinical examination and abdominal CT examination led to the diagnosis of mesenteric panniculitis. Drug treatment with NSAIDs and corticosteroids had a favorable outcome, confirming the autoimmune etiology of PM.

Conclusions. Mesenteric panniculitis is a rare pathology and its diagnosis is difficult to establish. The drug treatment with NSAIDs and corticosteroids can lead to good and lasting clinical results.

pdf

|Views: 209| |pdf Downloads: 175|


pdf
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Downloads

Download data is not yet available.

ANNOUNCEMENT

Starting from July 1, 2025, the article processing fee will be 20 EUR (or the equivalent in MDL at the official exchange rate of the National Bank of Moldova). The publication fee for an accepted article will be 150 EUR (or the equivalent in MDL).

Details here:

Processing Fee
A processing fee of 20 EUR (or the equivalent in MDL) will be charged for articles accepted for scientific review by the editorial committee of the One Health and Risk Management journal.
Note: This fee will only be charged if your article has been technically reviewed and accepted.

Publication Fee
Starting from 01.07.2025, a fee of 150 EUR (or the equivalent in MDL) will be charged for articles accepted for publication.
Additionally, authors will bear the cost of English language editing/translation services if the manuscript requires intervention. The fee is 5 EUR (or the equivalent in MDL) per page edited/translated.
The total cost for English editing/translation services will be communicated by the Editorial Board after the manuscript is accepted for publication.

Payment Details:
Payments should be made in MDL to the bank account opened in the name of the Biosafety and Biosecurity Association of the Republic of Moldova.
The invoice will be issued by the end of the month in which the payment was made.

Organization: Biosafety and Biosecurity Association of the Republic of Moldova
Address: 5C A. Cozmescu Street
Fiscal Code: 1017620004120
Bank Code (SWIFT): AGRNMD2X451
IBAN: MD34AG000000022513622370